免疫測定法の世界市場レポート 2025年

免疫測定法の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.4％で501億2,000万米ドルに成長します。予測期間の成長は、個別化医療、新興市場での拡大、パンデミック対策、がん診断、在宅検査へのシフトに起因すると考えられます。予測期間における主な動向としては、規制調和への取り組み、多目的免疫測定法、カスタマイズされた測定サービス、ウェアラブル機器との統合、測定機器の小型化などが挙げられます。

感染症や慢性疾患の蔓延は、今後の免疫測定法市場の成長を牽引すると予想されます。慢性疾患は一般に、1年以上持続し、継続的な診療が必要で、日常的な活動が制限される、またはその両方を伴う疾患と定義されます。感染症は、細菌、ウイルス、真菌、寄生虫などの生物によって引き起こされる病気です。人体の内部および表面には多数の微生物が共存しており、いくつかの感染症が人から人へと伝染する可能性があります。免疫測定法は様々な感染症や慢性疾患の検出に利用されています。例えば、米国の生物医学研究機関である国立衛生研究所（NIH）の報告書によると、2023年には、米国で少なくとも1つの慢性疾患を持つ50歳以上の高齢者の数は、2020年の7,152万2,000人から2050年には1億4,266万人へと99.5％増加すると予測されています。さらに、多疾患併存者の数は、2020年の783万400人から2050年には1,496万8,000人へと91.16％増加すると予測されています。したがって、感染症や慢性疾患の罹患率の増加が市場成長の原動力となっています。

ヘルスケアにおける政府主導の研究開発イニシアチブは、今後の免疫測定法市場の成長をサポートすると予想されます。こうした取り組みとは、特定の問題に取り組み、特定の目的を達成し、社会に前向きな変化をもたらすために、地方、地域、国、国際などさまざまなレベルの政府当局が実施する具体的な行動、プログラム、政策、プロジェクトを指します。このようなイニシアチブは、診断検査へのアクセスを改善し、ヘルスケアの質を向上させ、公衆衛生の課題に取り組むことを目的としており、免疫測定法の需要を促進しています。例えば、2022年に英国政府当局のDepartment of Health and Social Careは、ヘルスケアの研究と製造を強化するために2億6,000万ポンド（2億7,065万米ドル）の資金提供を発表しました。BEISとDHSCによるこの取り組みは、新しいプライバシー保護プラットフォームと臨床研究サービスを通じて、診断と治療に関するNHS主導の健康研究を支援することを目的としており、英国におけるライフサイエンス製造業の拡大を支援するために6,000万英ポンド（6,360万米ドル）が拠出されました。その結果、ヘルスケアにおける政府主導の開発研究イニシアチブが免疫測定法市場を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の免疫測定法市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の免疫測定法市場：成長率分析
• 世界の免疫測定法市場の実績：規模と成長、2019～2024年
• 世界の免疫測定法市場の予測：規模と成長、2024～2029年、2034年
• 世界の免疫測定法総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の免疫測定法市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 試薬・キット
• 分析装置または機器
• ソフトウェア・サービス
• 世界の免疫測定法市場：検体別、実績と予測、2019～2024年、2024～2029年、2034年
• 血液
• 唾液
• 尿
• その他
• 世界の免疫測定法市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 治療薬モニタリング
• 腫瘍学
• 心臓病学
• 内分泌学
• 感染症検査
• 自己免疫疾患
• その他
• 世界の免疫測定法市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 研究・学術研究室
• ホームケア設定
• 製薬・バイオテクノロジー企業・CRO
• 血液バンク
• 病院・診療所
• 臨床検査室
• 世界の免疫測定法市場、試薬・キットのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ELISAキット
• 迅速検査キット
• コントロール試薬
• アッセイ開発試薬
• 病院・診療所
• 世界の免疫測定法市場：分析装置または機器のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 自動分析装置
• ポイントオブケア検査装置
• マイクロプレートリーダー
• ルミノメーター
• 世界の免疫測定法市場：ソフトウェア・サービスのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• データ管理ソフトウェア
• 分析ソフトウェア
• サポートおよびメンテナンスサービス
• コンサルティングサービス

第7章 地域別・国別分析

• 世界の免疫測定法市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の免疫測定法市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 免疫測定法市場：競合情勢
• 免疫測定法市場：企業プロファイル
  • Siemens Healthineers GmbH Overview, Products and Services, Strategy and Financial Analysis
  • bioMerieux Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Overview, Products and Services, Strategy and Financial Analysis
  • Beckman Coulter Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Ortho Clinical Diagnostics
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• Becton Dickinson and Company
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Agilent Technologies Inc.
• PerkinElmer Inc
• WAK-Chemie Medical GmbH
• J Mitra & Co Pvt Ltd
• Kamiya Biomedical Company
• Tosoh Corporation
• Gyros Protein Technologies AB
• BioCheck Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 免疫測定法市場2029年：新たな機会を提供する国
• 免疫測定法市場2029年：新たな機会を提供するセグメント
• 免疫測定法市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Immunoassay is a bioanalytical test that utilizes the binding of antibodies to antigens to detect and quantify specific chemicals, playing a crucial role in the diagnosis of diseases. Information derived from immunoassay test results can be used to establish appropriate courses of therapy. This method relies on a competitive binding reaction between a limited number of receptors on a highly specific anti-analyte antibody, labeled versions of an analyte, and a significant portion of an unlabeled sample analyte.

The main types of immunoassay products include reagents and kits, analyzers or instruments, and software and services. Reagents are substances or products that accelerate a reaction and are commonly used in various tests. Immunoassay specimens include blood, saliva, urine, and others, and the technique is applied in therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease testing, autoimmune diseases, and more. The end users of immunoassay products are diverse and include research and academic laboratories, home care settings, pharmaceutical and biotechnology companies, Contract Research Organizations (CROs), blood banks, hospitals and clinics, and clinical laboratories.

The immunoassay market research report is one of a series of new reports from The Business Research Company that provides immunoassay market statistics, including immunoassay industry global market size, regional shares, competitors with a immunoassay market share, detailed immunoassay market segments, market trends and opportunities, and any further data you may need to thrive in the immunoassay industry. This immunoassay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunoassay market size has grown strongly in recent years. It will grow from $35.81 billion in 2024 to $37.63 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to disease prevalence, aging population, infectious disease outbreaks, point-of-care testing, increased research funding.

The immunoassay market size is expected to see strong growth in the next few years. It will grow to $50.12 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to personalized medicine, expansion in emerging markets, pandemic preparedness, cancer diagnostics, shift to home-based testing. Major trends in the forecast period include regulatory harmonization efforts, multipurpose immunoassays, customized assay services, integration with wearable devices, and miniaturization of assays.

The growing prevalence of infectious and chronic diseases is expected to drive the growth of the immunoassay market in the near future. Chronic illnesses are generally defined as conditions that last for a year or longer, require ongoing medical attention, restrict daily activities, or both. Infectious diseases are illnesses caused by organisms such as bacteria, viruses, fungi, or parasites. Numerous organisms coexist within and on the human body, and several infectious diseases can be transmitted from one person to another. Immunoassays are utilized to detect various infectious and chronic diseases. For example, a report from the National Institutes of Health (NIH), a US-based biomedical research agency, stated that in 2023, the number of individuals aged 50 and older in the United States with at least one chronic illness is projected to increase by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Moreover, the number of people with multimorbidity is expected to rise by 91.16%, from 7.8304 million in 2020 to 14.968 million by 2050. Therefore, the increasing incidence of infectious and chronic diseases is driving market growth.

Government-led research and development initiatives in healthcare are anticipated to support the growth of the immunoassay market in the future. These initiatives refer to specific actions, programs, policies, or projects undertaken by government authorities at various levels-local, regional, national, or international-to tackle specific issues, achieve certain objectives, or foster positive changes in society. Such initiatives have aimed at improving access to diagnostic testing, enhancing healthcare quality, and addressing public health challenges, thereby driving demand for immunoassays. For instance, in 2022, the Department of Health and Social Care, a UK government authority, announced £260 million (US$270.65 million) in funding to enhance healthcare research and manufacturing. This commitment, made by BEIS and DHSC, was aimed at supporting NHS-led health research into diagnostics and treatment through new privacy-preserving platforms and clinical research services, along with £60 million (US$63.60 million) to aid in expanding life sciences manufacturing in the UK. Consequently, the growth of government initiatives in healthcare is driving the immunoassay market.

A key trend gaining momentum is product innovation, with major companies striving to strengthen their market position through cutting-edge offerings. For instance, Getein Biotech Inc., a China-based biotechnological company, introduced the MAGICL 6000 at MEDICA 2022. This portable chemiluminescence immunoassay analyzer is designed for labs with mid- to high-workflow requirements, providing a one-step chemiluminescence solution. The instrument stands out for its efficiency, compact size, complete automation, and rapid assessment frequency, offering a technologically advanced option for diagnostic laboratories.

Major players in the immunoassay market are introducing innovative immunoassay analyzers to gain a competitive advantage. These analyzers automate the detection and quantification of biological molecules, such as proteins or hormones, through immunological reactions. Beckman Coulter Diagnostics launched the DxI 9000 Access Immunoassay Analyzer in May 2023, addressing the needs of clinical laboratories for speed, reliability, reproducibility, and expanded menu options. The analyzer incorporates advanced features such as new analyte processing and detection technology, precision sensors, smart algorithms, and remote real-time system monitoring. Its distinctive feature includes no daily maintenance, enhancing its efficiency in diagnostic workflows.

In January 2023, Heska Corporation, a US-based biotechnology firm, acquired MBio Diagnostics, Inc. for an undisclosed sum. This acquisition is intended to strengthen Heska Corporation's research, development, and manufacturing capabilities, primarily by incorporating LightDeck's innovative point-of-care technology. This integration will facilitate the launch of advanced diagnostic platforms, including a product for canine cancer screening. MBio Diagnostics, Inc. is a US-based company that specializes in immunoassays.

Major companies operating in the immunoassay market include Siemens Healthineers GmbH, bioMerieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

North America was the largest region in the immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the immunoassay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The immunoassay market includes revenues earned by entities by supplying immunoassay kits, analyzers, and reagents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunoassay Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunoassay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunoassay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The immunoassay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Reagents And Kits; Analyzers Or Instruments; Software And Services
• 2) By Specimen: Blood; Saliva; Urine; Other Specimens
• 3) By Application: Therapeutic Drug Monitoring; Oncology; Cardiology; Endocrinology; Infectious Disease Testing; Autoimmune Diseases; Other Applications
• 4) By End User: Research And Academic Laboratories; Home Care Settings; Pharmaceutical And Biotechnology Companies And CROs; Blood Banks; Hospitals And Clinics; Clinical Laboratories
• Subsegments:
• 1) By Reagents And Kits: ELISA Kits; Rapid Test Kits; Control Reagents; Assay Development Reagents
• 2) By Analyzers Or Instruments: Automated Analyzers; Point-Of-Care Testing Devices; Microplate Readers; Luminometers
• 3) By Software And Services: Data Management Software; Analytical Software; Support And Maintenance Services; Consulting Services
• Companies Mentioned: Siemens Healthineers GmbH; bioMerieux; Abbott; Beckman Coulter Inc.; Quidel Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Immunoassay Market Characteristics

3. Immunoassay Market Trends And Strategies

4. Immunoassay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Immunoassay Growth Analysis And Strategic Analysis Framework

• 5.1. Global Immunoassay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Immunoassay Market Growth Rate Analysis
• 5.4. Global Immunoassay Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Immunoassay Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Immunoassay Total Addressable Market (TAM)

6. Immunoassay Market Segmentation

• 6.1. Global Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Kits
• Analyzers Or Instruments
• Software And Services
• 6.2. Global Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood
• Saliva
• Urine
• Other Specimens
• 6.3. Global Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutic Drug Monitoring
• Oncology
• Cardiology
• Endocrinology
• Infectious Disease Testing
• Autoimmune Diseases
• Other Applications
• 6.4. Global Immunoassay Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research And Academic Laboratories
• Home Care Settings
• Pharmaceutical And Biotechnology Companies And CROs
• Blood Banks
• Hospitals And Clinics
• Clinical Laboratories
• 6.5. Global Immunoassay Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• ELISA Kits
• Rapid Test Kits
• Control Reagents
• Assay Development Reagents
• Hospitals And Clinics
• 6.6. Global Immunoassay Market, Sub-Segmentation Of Analyzers Or Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Analyzers
• Point-Of-Care Testing Devices
• Microplate Readers
• Luminometers
• 6.7. Global Immunoassay Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Management Software
• Analytical Software
• Support And Maintenance Services
• Consulting Services

7. Immunoassay Market Regional And Country Analysis

• 7.1. Global Immunoassay Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Immunoassay Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunoassay Market

• 8.1. Asia-Pacific Immunoassay Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunoassay Market

• 9.1. China Immunoassay Market Overview
• 9.2. China Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunoassay Market

• 10.1. India Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunoassay Market

• 11.1. Japan Immunoassay Market Overview
• 11.2. Japan Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunoassay Market

• 12.1. Australia Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunoassay Market

• 13.1. Indonesia Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunoassay Market

• 14.1. South Korea Immunoassay Market Overview
• 14.2. South Korea Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunoassay Market

• 15.1. Western Europe Immunoassay Market Overview
• 15.2. Western Europe Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunoassay Market

• 16.1. UK Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunoassay Market

• 17.1. Germany Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunoassay Market

• 18.1. France Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunoassay Market

• 19.1. Italy Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunoassay Market

• 20.1. Spain Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunoassay Market

• 21.1. Eastern Europe Immunoassay Market Overview
• 21.2. Eastern Europe Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunoassay Market

• 22.1. Russia Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunoassay Market

• 23.1. North America Immunoassay Market Overview
• 23.2. North America Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunoassay Market

• 24.1. USA Immunoassay Market Overview
• 24.2. USA Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunoassay Market

• 25.1. Canada Immunoassay Market Overview
• 25.2. Canada Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunoassay Market

• 26.1. South America Immunoassay Market Overview
• 26.2. South America Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunoassay Market

• 27.1. Brazil Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunoassay Market

• 28.1. Middle East Immunoassay Market Overview
• 28.2. Middle East Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunoassay Market

• 29.1. Africa Immunoassay Market Overview
• 29.2. Africa Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunoassay Market Competitive Landscape And Company Profiles

• 30.1. Immunoassay Market Competitive Landscape
• 30.2. Immunoassay Market Company Profiles
  • 30.2.1. Siemens Healthineers GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. bioMerieux Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Beckman Coulter Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Immunoassay Market Other Major And Innovative Companies

• 31.1. Ortho Clinical Diagnostics
• 31.2. Sysmex Corporation
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. Becton Dickinson and Company
• 31.5. F. Hoffmann-La Roche Ltd
• 31.6. Thermo Fisher Scientific Inc.
• 31.7. Merck KGaA
• 31.8. Agilent Technologies Inc.
• 31.9. PerkinElmer Inc
• 31.10. WAK-Chemie Medical GmbH
• 31.11. J Mitra & Co Pvt Ltd
• 31.12. Kamiya Biomedical Company
• 31.13. Tosoh Corporation
• 31.14. Gyros Protein Technologies AB
• 31.15. BioCheck Inc.

32. Global Immunoassay Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunoassay Market

34. Recent Developments In The Immunoassay Market

35. Immunoassay Market High Potential Countries, Segments and Strategies

• 35.1 Immunoassay Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Immunoassay Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Immunoassay Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer